Genentech ending commercial manufacturing, 265 jobs at 40-year-old South S.F. facility

The facility that produced the Genentech-defining cancer drugs Avastin and Herceptin as well as 10 others is stopping commercial manufacturing.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news